CureVac

Latest

BioNTech, CureVac, Moderna: mRNA technology – potential to revolutionize medicine – Commerzbank column

The new “mRNA vaccines” are not only considered a major milestone in the fight against the corona pandemic – the…

Read More »
Latest

CureVac: COVID-19 vaccine shows “strong immune response” preclinically – shares weak

CureVac released new test data on Wednesday for the potential, previously unapproved COVID-19 vaccine CVnCoV. In non-human primates, the vaccine…

Read More »
Latest

Bayer stock after the CureVac deal: reversed trend? – Chart analysis

Bayer stock, a previous “problem child” in the DAX, has performed significantly better since the multi-year low of EUR 39.91…

Read More »
Latest

In the morning: Bayer, CureVac, LafargeHolcim and Ryanair in focus – Nord LB column

Despite the partial lockdown, German industry surprisingly received more orders for the seventh month in a row. New business grew…

Read More »
Latest

CureVac share: heading back towards all-time high after Bayer deal? – Chart analysis

The Bayer deal yesterday brought plenty of momentum to the CureVac share. At the beginning of trading, the US technology…

Read More »
Markets

Alliance against Corona – Bayer and Curevac join forces – columns

Important instructions This document was created by HSBC Trinkaus & Burkhardt AG (“HSBC”). It is for informational purposes only and…

Read More »
Latest

CureVac share: something could happen here! – Chart analysis

Yesterday, the CureVac share on the NASDAQ started again on the 50-day line – and as on Monday, the break…

Read More »
Latest

CureVac share missed new buy signal: That went unpleasantly wrong … – Chart analysis

On the NASDAQ, the CureVac share failed yesterday’s first attempt to get the biotech stock out of the downward movement…

Read More »
Latest

CureVac share: is the turning point coming now? – Chart analysis

Not only the BioNTech share was under significant pressure after a new all-time high in December 2020, but also the…

Read More »
Latest

CureVac and BioNTech in the spotlight amid the emerging COVID-19 mutation panic

At the weekend, Great Britain caused a new COVID-19 shock with reports of mutated SARS-CoV-2 viruses, which this morning is…

Read More »
Back to top button
Close
Close